MARKET NEWS

The Pistoia Alliance Calls on Life Science & Healthcare Ecosystems to Restructure Around Patient Centricity
BriaCell Receives FDA Fast Track Approval for Targeted Breast Cancer Immunotherapy
Artelo Biosciences Reports Positive Preclinical Results for Lead Program in Cancer-Related Cachexia
ChemoCentryx Reports PK & PD Results From Ongoing Phase 1 Trial of Orally Administered PD-L1 Inhibitor
Geocann & Averix Bio Form Strategic Partnership to Supply Global Marketplace With Pharmaceutical API Phytocannabinoid Ingredients Formulated With Proven Delivery System
Inozyme Pharma Provides Update for Phase 1/2 Clinical Trials in ABCC6 Deficiency & ENPP1 Deficiency

  FEATURED EDITORIAL

  COMPANY PROFILE

Video Spotlight: Ajinomoto (Lust Fill Line 2)



Video Spotlight: Lonza (Small Molecules)

  EXCLUSIVE ONLINE CONTENT

Imcyse Announces First Patient Dosed in Adaptive Phase 1/2 Clinical Trial for Multiple Sclerosis

Imcyse Announces First Patient Dosed in Adaptive Phase 1/2 Clinical Trial for Multiple Sclerosis

Imcyse recently announced the first patient has been dosed in the adaptive Phase 1/2 clinical trial evaluating Imotope IMCY-0141 in patients with relapsing-remitting multiple sclerosis….

Venomtech Announces New Drug Development Collaboration With Charles River

Venomtech Announces New Drug Development Collaboration With Charles River

Venomtech is collaborating with Charles River Laboratories, International Inc. to help drug developers explore venom-derived compounds for a wide range of….

Matinas BioPharma & BioNTech Announce Exclusive Research Collaboration to Evaluate Novel Delivery Technology for mRNA-based Vaccines

Matinas BioPharma & BioNTech Announce Exclusive Research Collaboration to Evaluate Novel Delivery Technology for mRNA-based Vaccines

Matinas BioPharma and BioNTech SE recently announced they have entered into an exclusive research collaboration to evaluate the combination of mRNA formats and….

Eton Pharmaceuticals Announces FDA Approval of Cysteine Hydrochloride Injection

Eton Pharmaceuticals Announces FDA Approval of Cysteine Hydrochloride Injection

Eton Pharmaceuticals, Inc. recently announced it has received final approval from the US FDA for its cysteine hydrochloride abbreviated new drug application (ANDA), a bioequivalent generic of….

  WHITEPAPERS & WEBINARS

On Demand Webinar – Emergent CDMO: High-Speed Manufacturing Solutions for Your Viral Vaccine or Therapeutic

On Demand Webinar – Emergent CDMO: High-Speed Manufacturing Solutions for Your Viral Vaccine or Therapeutic

Emergent and groniger partner to present the benefits and features of the INTEGRA® high-speed aseptic fill line with isolator technology for viral vaccines and therapeutics.

Oral Delivery of Hydrophilic Macromolecules: Lipid-Based Nanocarriers as Key to Success

Oral Delivery of Hydrophilic Macromolecules: Lipid-Based Nanocarriers as Key to Success

This LIVE event has already taken place CLICK HERE to access the recorded version of this event and receive a copy of the presentation. Join…

  WHITEPAPERS & WEBINARS

WHITE PAPER: Controlled Synthesis of Lipid Nanoparticles Using the Automated Nanoparticle System

WHITE PAPER: Controlled Synthesis of Lipid Nanoparticles Using the Automated Nanoparticle System

ABSTRACT

Lipid nanoparticles (LNPs) are powerful carriers for the delivery of biotherapeutics and active pharmaceutical ingredients (APIs). They are attractive due to their size and biocompatibility, which are important factors when determining the efficacy of an encapsulated API. Particle Works’ …

WHITE PAPER: Tackling a Changing Climate; Metered Dose Inhalers | Recipharm

WHITE PAPER: Tackling a Changing Climate; Metered Dose Inhalers | Recipharm

Are you prepared for the HFA phasedown? With many industries switching to more environmentally friendly propellants, pMDI developers need to be ready. Recipharm explore alternative technologies to HFA propellants, and how the devices and formulations can be optimized to ensure …

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

April 27 – Formulation Development
May 4 – Prefilled Syringes